Scavenger receptor class BI (SR-BI) mediates uptake of CPX-351 into K562 leukemia cells
Sign Up to like & getrecommendations! Published in 2019 at "Drug Development and Industrial Pharmacy"
DOI: 10.1080/03639045.2018.1513026
Abstract: Abstract Purpose: CPX-351 is a liposomal formulation of cytarabine and daunorubicin encapsulated at a 5:1 molar ratio, for the treatment of acute myeloid leukemia. The Scavenger Receptor class B type I (SR-BI) plays an important… read more here.
Keywords: k562; receptor class; uptake cpx; cpx 351 ... See more keywords